The conference embraced change as it focused on cutting-edge technology under the theme “Life-Changing Research.”
Sunali Goyal, MD, weighed in on the ongoing controversy surrounding aspirin’s association with AMD during Monday’s session on translational research at ARVO.
Under the deal, Valeant will acquire Bausch + Lomb from the private equity firm Warburg Pincus LLC. Bausch + Lomb will keep its name and become a division of Valeant.
Few new technologies have garnered the amount of attention given to refractive
laser-assisted cataract surgery.
ReLACS used with USP continues to gain traction and is adding a new layer of revenue to the cataract equipment market while at the same time helping to expand the premium private-pay cataract surgery channel globally.
The legislation was passed out of committee on May 22 and now heads for the full Senate floor.
Market Scope expects the market to generate $2.4 billion in sales in 2013, growing to $3.0 billion by 2018.
You are not currently logged in.
©2017 Market Scope
Lost your Password